BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23813877)

  • 1. MicroRNA-146b improves intestinal injury in mouse colitis by activating nuclear factor-κB and improving epithelial barrier function.
    Nata T; Fujiya M; Ueno N; Moriichi K; Konishi H; Tanabe H; Ohtake T; Ikuta K; Kohgo Y
    J Gene Med; 2013; 15(6-7):249-60. PubMed ID: 23813877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-146b-5p regulates bone marrow mesenchymal stem cell differentiation by SIAH2/PPARγ in aplastic anemia children and benzene-induced aplastic anemia mouse model.
    Li H; Xu X; Wang D; Zeng L; Li B; Zhang Y; Su S; Wei L; You H; Fang Y; Wang Y; Liu Y
    Cell Cycle; 2020 Oct; 19(19):2460-2471. PubMed ID: 32840137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipokine C1q/Tumor Necrosis Factor- Related Protein 3 (CTRP3) Attenuates Intestinal Inflammation Via Sirtuin 1/NF-κB Signaling.
    Yu H; Zhang Z; Li G; Feng Y; Xian L; Bakhsh F; Xu D; Xu C; Vong T; Wu B; Selaru FM; Wan F; Donowitz M; Wong GW
    Cell Mol Gastroenterol Hepatol; 2023; 15(4):1000-1015. PubMed ID: 36592863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-146b, a Sensitive Indicator of Mesenchymal Stem Cell Repair of Acute Renal Injury.
    Zhu Y; Yu J; Yin L; Zhou Y; Sun Z; Jia H; Tao Y; Liu W; Zhang B; Zhang J; Wang M; Zhang X; Yan Y; Xue J; Gu H; Mao F; Xu W; Qian H
    Stem Cells Transl Med; 2016 Oct; 5(10):1406-1415. PubMed ID: 27400799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-129/FBW7/NF-κB, a Novel Regulatory Pathway in Inflammatory Bowel Disease.
    Meng Q; Wu W; Pei T; Xue J; Xiao P; Sun L; Li L; Liang D
    Mol Ther Nucleic Acids; 2020 Mar; 19():731-740. PubMed ID: 31945730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal epithelial Krüppel-like factor 4 alleviates endotoxemia and atherosclerosis through improving NF-κB/miR-34a-mediated intestinal permeability.
    Nie HZ; Zhou YW; Yu XH; Yin CG; Li LF; Hao HQ; Yuan T; Pan Y
    Acta Pharmacol Sin; 2024 Jun; 45(6):1189-1200. PubMed ID: 38438579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on the Role of P21-Activated Kinase 1 (PAK1) in the Intestinal Anti-inflammatory and Antitumor Potential of Artepillin C.
    da Silva LM
    Curr Mol Pharmacol; 2024; 17(1):e260423216212. PubMed ID: 37185322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Autophagy and Related MicroRNAs in Inflammatory Bowel Disease.
    Wang S; Huang Y; Zhou C; Wu H; Zhao J; Wu L; Zhao M; Zhang F; Liu H
    Gastroenterol Res Pract; 2018; 2018():7565076. PubMed ID: 30046303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine Colostrum miR-30a-5p Targets the NF-κB Signaling Pathway to Alleviate Inflammation in Intestinal Epithelial Cells.
    Zhang C; Zheng J; Han X; Zhao J; Cheng S; Li A
    J Agric Food Chem; 2024 Apr; ():. PubMed ID: 38606544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulatory NLRs mitigate inflammation via NF-κB pathway signaling in inflammatory bowel disease.
    Morrison HA; Trusiano B; Rowe AJ; Allen IC
    Biomed J; 2023 Oct; 46(5):100616. PubMed ID: 37321320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Supercarbonate Apatite-MicroRNA Complex Inhibits Dextran Sodium Sulfate-Induced Colitis.
    Fukata T; Mizushima T; Nishimura J; Okuzaki D; Wu X; Hirose H; Yokoyama Y; Kubota Y; Nagata K; Tsujimura N; Inoue A; Miyoshi N; Haraguchi N; Takahashi H; Hata T; Matsuda C; Kayama H; Takeda K; Doki Y; Mori M; Yamamoto H
    Mol Ther Nucleic Acids; 2018 Sep; 12():658-671. PubMed ID: 30092402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-200 Loaded Lipid Nanoparticles Promote Intestinal Epithelium Regeneration in Canonical MicroRNA-Deficient Mice.
    Wei X; Yu S; Zhang T; Liu L; Wang X; Wang X; Chan YS; Wang Y; Meng S; Chen YG
    ACS Nano; 2023 Nov; 17(22):22901-22915. PubMed ID: 37939210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of microRNA-135a in colitis.
    Lou C; Li Y
    J Inflamm (Lond); 2018; 15():7. PubMed ID: 29636643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA-Approved Excipient N, N-Dimethylacetamide Attenuates Inflammatory Bowel Disease in
    Koya JB; Shen T; Lu G; Gauthier A; Mantell L; Ashby CR; Reznik SE
    Fortune J Health Sci; 2022; 5():499-509. PubMed ID: 37886658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stilbenoid compounds inhibit NF-κB-mediated inflammatory responses in the
    Aalto AL; Saadabadi A; Lindholm F; Kietz C; Himmelroos E; Marimuthu P; Salo-Ahen OMH; Eklund P; Meinander A
    Front Immunol; 2023; 14():1253805. PubMed ID: 37809071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIF1α/miR-146α/TRAF6/NF-κB axis modulates hepatic iron overload-induced inflammation.
    Mo F; Tang Y; Shen H; Wu L; Liu Q; Nie S; Li M; Ling C
    J Nutr Biochem; 2024 Mar; 125():109499. PubMed ID: 37875229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA Cdr1as inhibits proliferation and delays injury-induced regeneration of the intestinal epithelium.
    Chung HK; Xiao L; Han N; Chen J; Yao V; Cairns CM; Raufman B; Rao JN; Turner DJ; Kozar R; Gorospe M; Wang JY
    JCI Insight; 2024 Jan; 9(4):. PubMed ID: 38227372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Wheat peptides inhibit the activation of MAPK and NF-κB inflammatory pathways and maintain epithelial barrier integrity in NSAID-induced intestinal epithelial injury.
    Feng Z; Wei Y; Zhang Z; Li M; Gu R; Lu L; Liu W; Qin H
    Food Funct; 2024 Feb; 15(3):1720. PubMed ID: 38226873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction to Epac-2 ameliorates spontaneous colitis in Il-10
    J Cell Mol Med; 2023 Nov; 27(21):3419-3421. PubMed ID: 37608760
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenotypic MicroRNA Microarrays.
    Kwon YJ; Heo JY; Kim HC; Kim JY; Liuzzi M; Soloveva V
    Microarrays (Basel); 2013 Apr; 2(2):63-80. PubMed ID: 27605181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.